MTUS1抗体—艾普蒂 新品

+ +

•  

   

     The image is immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using P08533(MTUS1 Antibody) at dilution 1/20. (Original magnification: ×200)    

  
  

•  

   

     The image is immunohistochemistry of paraffin-embedded Human brain  tissue using P08533(MTUS1 Antibody) at dilution 1/20. (Original magnification: ×200)    

  
  

The MTUS1 (Microtubule Associated Tumor Suppressor 1) antibody is a tool used to study the MTUS1 protein, encoded by the *MTUS1* gene, which acts as a tumor suppressor in various cancers. MTUS1 interacts with microtubules and regulates cell proliferation, migration, and apoptosis. It contains multiple isoforms, including ATIP (Angiotensin II AT2 Receptor-Interacting Protein) family members, which participate in signaling pathways such as ERK and p53. Research shows MTUS1 is frequently downregulated in cancers (e.g., breast, colorectal, lung) due to promoter hypermethylation or deletions, correlating with poor prognosis. Its loss promotes tumor growth, angiogenesis, and metastasis.

MTUS1 antibodies are essential for detecting protein expression levels, localization, and isoform-specific functions in cell lines or tissues. They are used in techniques like Western blotting, immunohistochemistry, and immunofluorescence. Studies employing these antibodies have revealed MTUS1's role in microtubule dynamics, cell cycle arrest, and interactions with oncogenic pathways. Commercial MTUS1 antibodies vary in specificity, targeting epitopes in conserved regions (e.g., N-terminal) to ensure cross-reactivity across isoforms. Validation includes knockdown experiments or MTUS1-deficient samples to confirm target accuracy. Ongoing research explores its therapeutic potential as a biomarker or target in precision oncology.